Download Free Sample Report

The global Acute Kidney Injury Treatment & Management market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

KI happens in people who are already sick and in the hospital. People who are in the intensive care unit (ICU) are even more likely than people who are in other units of the hospital to have AKI. This is because people who need to be in the ICU are already very sick.
This report aims to provide a comprehensive presentation of the global market for Acute Kidney Injury Treatment & Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Kidney Injury Treatment & Management. This report contains market size and forecasts of Acute Kidney Injury Treatment & Management in global, including the following market information:

• Global Acute Kidney Injury Treatment & Management Market Revenue, 2018-2023, 2024-2032, ($ millions)
• Global top five companies in 2022 (%)

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prerenal Acute Kidney Injury Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Kidney Injury Treatment & Management include B. Braun Melsungen AG, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Angion Biomedica Corp, AM-Pharma, Quark Pharmaceuticals, Inc and Fresenius Medical Care AG & Co. KGaA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Kidney Injury Treatment & Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Kidney Injury Treatment & Management Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Acute Kidney Injury Treatment & Management Market Segment Percentages, by Type, 2022 (%)

• Prerenal Acute Kidney Injury
• Intrinsic Renal Acute Kidney Injury
• Postrenal Acute Kidney Injury

Global Acute Kidney Injury Treatment & Management Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Acute Kidney Injury Treatment & Management Market Segment Percentages, by Application, 2022 (%)

• Hospitals
• Ambulatory Surgical Centers
• Others

Global Acute Kidney Injury Treatment & Management Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Acute Kidney Injury Treatment & Management Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Acute Kidney Injury Treatment & Management revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Acute Kidney Injury Treatment & Management revenues share in global market, 2022 (%)

Key players include:

• B. Braun Melsungen AG
• Baxter International, Inc.
• Asahi Kasei Medical Co., Ltd
• Angion Biomedica Corp
• AM-Pharma
• Quark Pharmaceuticals, Inc
• Fresenius Medical Care AG & Co. KGaA

Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Kidney Injury Treatment & Management, market overview.
Chapter 2: Global Acute Kidney Injury Treatment & Management market size in revenue.
Chapter 3: Detailed analysis of Acute Kidney Injury Treatment & Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Kidney Injury Treatment & Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.